Valeant的CEO Michael Pearson 5月21日在参加彭博加拿大经济峰会期间接受彭博社记者Jason Kelly采访。Pearson评价当前医疗行业的并购活动“有点泡沫”，表示Valeant正在通过收购成为全球最大的制药公司之一，并称“我们喜欢亚洲”。

Valeant’s Pearson Sees ‘Bit of a Bubble’ in Health-Care M&A

Valeant Pharmaceuticals International Inc. Chief Executive Officer Michael Pearson called the acquisition activity in the health-care sector a “bit of a bubble.”

“There’s a deal frenzy going on. Some of these acquisitions are not going to work,” Pearson said Thursday at the Bloomberg Canada Economic Series in Toronto. “In terms of prices being paid for acquisitions, some of them make sense and some of them don’t make sense.”

Valeant is seeking to become one of the world’s biggest drug companies, mostly through acquisitions, amid a flurry of transactions in the global pharmaceuticals and biotechnology industries that included almost $100 billion worth of deals in the first quarter.

Valeant is in talks to acquire Amoun Pharmaceutical Co., one of the largest drugmakers in Egypt, according to people with knowledge of the matter, Bloomberg reported Wednesday. Pearson declined to comment on Amoun in a separate interview Thursday.

Valeant spent much of 2014 embroiled in an unsuccessful hostile takeover battle for botox-maker Allergan Inc. Earlier this year the company beat out rival Endo International Plc to buy Salix Pharmaceuticals Ltd. for $11.1 billion.

‘Like Asia’

The company is also interested in further growth in Asia, Pearson said.

“We like Asia,” he said after his on-stage interview. “Business is doing well. There’s a huge unmet need and incomes are going to continue to rise. We have been and we will continue to make acquisitions.”

Canada is also an area where Valeant has been expanding, with operations totaling some C$400 million ($328 million) in its pharmaceuticals, over-the-counter drugs and Bausch & Lomb contact-lens business.

“We are now exiting parts of North America and moving them to Canada because of the exchange rate, and also a lot of other pharmaceutical companies are moving out of Canada,” Pearson said.

“There’s a talented workforce and an overcapacity of workers,” he said. “We’ve tripled our workforce in Canada in the last three or four years.”